Danish pharma leader Novo Nordisk has thrown its weight behind the Chinese mainland’s latest healthcare push, signaling strong confidence in the local market. At a recent forum, the company’s chairman applauded national efforts to strengthen care networks and forge a path toward universal health coverage.
The Chinese mainland’s reforms spotlight digital health, preventative care and rural outreach. This multi-pronged approach aims to address rising chronic diseases, including diabetes, which affects millions across the population.
For its part, Novo Nordisk is scaling up local research and development, partnering with hospitals and training healthcare professionals. By investing in cutting-edge treatments and community programs, the company hopes to play a pivotal role in addressing the diabetes challenge.
Looking ahead, stronger public-private collaboration could reshape global health trends. As the Chinese mainland charts a healthier future, Novo Nordisk’s endorsement underscores the growing synergy between global innovators and local initiatives.
Reference(s):
cgtn.com
